Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Medicinal Chemistry|March 31, 2020
Research progress on sirtuins family members and cell senescenceTing Wang, Yujue Wang, Li Liu, et al.
Disease Markers|October 26, 2020
Diagnosis Test Meta-Analysis for Apolipoprotein E in Alzheimer's DiseaseXuan Xiong, Hongtao Xiao, Yuan Zhang, et al.
Medicine|August 16, 2021
Association between CYP2B6 c.516G >T variant and acute leukaemia: A protocol for systematic review and meta-analysisXuan Xiong, Dongke Yu, Qiaoyue Gao, et al.
Molecular Medicine Reports|October 4, 2018
Mangiferin: An effective therapeutic agent against several disorders (Review)Suya Du, Huirong Liu, Tiantian Lei, et al.
Frontiers in Pharmacology|January 8, 2024
Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseasesQinan Yin, Xingyue Zheng, Yujie Song, et al.
European Journal of Medicinal Chemistry|March 26, 2018
Inhibitors of phosphodiesterase as cancer therapeuticsTing Peng, Jun Gong, Yongzhe Jin, et al.
Chemistry & Biodiversity|July 25, 2019
Design, Synthesis and in Vitro Tumor Cytotoxicity Evaluation of 3,5-Diamino-N-substituted Benzamide Derivatives as Novel GSK-3β Small Molecule InhibitorsYanping Zhou, Lijuan Zhang, Xiujuan Fu, et al.
Combinatorial Chemistry & High Throughput Screening|December 4, 2015
An Integrated In Silico Method to Discover Novel Rock1 Inhibitors: Multi- Complex-Based Pharmacophore, Molecular Dynamics Simulation and Hybrid Protocol Virtual ScreeningHaining Chen, Sijia Li, Yajiao Hu, et al.
Oncotarget|January 5, 2018
PKM2 in carcinogenesis and oncotherapyXia He, Suya Du, Tiantian Lei, et al.
Bioorganic Chemistry|October 27, 2022
HDAC/JAK dual target inhibitors of cancer-related targets: The success of nonclearable linked pharmacophore modeLiyun Zhao, Qi Liang, Ye He, et al.
Pageof 11